Summit Therapeutics Inc. (SMMT) Earnings Call Transcript & Summary

June 24, 2020

NASDAQ US Health Care Biotechnology shareholder_meeting 2 min

Earnings Call Speaker Segments

Operator

operator
#1

Ladies and gentlemen, thank you for standing by, and welcome to the Summit Therapeutics Annual General Meeting. [Operator Instructions] Also I must advise that the call is being recorded today, Wednesday, the 24th of June 2020. And without any further delay, I would now like to hand over the call to your speaker today, Ms. Melissa Strange. Thank you. Please go ahead.

Melissa Strange

executive
#2

Thank you. Good afternoon, ladies and gentlemen. It is now 3:00 p.m. 2 members of the company entitled to vote at the Annual General Meeting are present in person. A quorum is therefore present, and the meeting can proceed. I will begin by introducing myself. I am Melissa Strange, the company's Secretary and Vice President of Finance. Due to the COVID-19 pandemic, our directors are unable to attend today and send their apologies. Pursuant to the Articles of Association of the Company, as no director is present at this General Meeting, the members of the company present and entitled to vote at the meeting should elect one of the members to be the Chairman of the meeting. Accordingly, I propose that I, Melissa Strange, should be the Chairman of this Annual General Meeting. With all those in favor, please raise their hands. [Voting]

Melissa Strange

executive
#3

I declare the proposal approved. The notice convening the Annual General Meeting was issued by the company and made available to shareholders on the 29th of May 2020. It has become apparent that the company needs to clarify the voting intentions of certain shareholders in order to ensure that such intentions are properly reflected at this meeting. Accordingly, I propose that the meeting be adjourned until 3:00 p.m. on the 25th of June 2020. Would all those in favor, please raise their hands? [Voting]

Melissa Strange

executive
#4

I declare the proposal approved. Thank you. No questions from shareholders have been received in advance of today's meeting. The 2020 Annual General Meeting of Summit Therapeutics plc will now be adjourned to 3:00 p.m. on the 25th of June 2020. Results from the meeting will be posted to our website at www.summitplc.com. Thank you.

Operator

operator
#5

So that does conclude our conference for today. Thank you all for participating. You may all disconnect.

For developers and AI pipelines

Programmatic access to Summit Therapeutics Inc. earnings transcripts and 32,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.